In contrast, the STK11-SNP was significantly associated with reduced MSSS (3.99 ± 0.10 vs. 3.37 ± 0.28, p = .044) across all MS patients (Figure 3(b)). The gene discussed is STK11; the disease is myeloid sarcoma.